DOI:
10.1055/s-00035331
Revista Urología Colombiana / Colombian Urology Journal
LinksClose Window
References
Drake MJ, Chapple C, Esen AA. et al; BESIDE study investigators.
Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE).
Eur Urol 2016;
70 (01) 136-145
DOI: 10.1016/j.eururo.2016.02.030.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.